NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,029,045 | -40.7% | 313,686 | -21.6% | 0.00% | 0.0% |
| Q2 2023 | $10,168,128 | -32.8% | 400,005 | -4.5% | 0.00% | -50.0% |
| Q1 2023 | $15,135,247 | -29.7% | 418,679 | -23.0% | 0.00% | 0.0% |
| Q4 2022 | $21,543,113 | +7.0% | 544,018 | +25.9% | 0.00% | -33.3% |
| Q3 2022 | $20,135,000 | -8.1% | 432,071 | -13.5% | 0.00% | 0.0% |
| Q2 2022 | $21,906,000 | -39.6% | 499,767 | -0.3% | 0.00% | -40.0% |
| Q1 2022 | $36,269,000 | +25.8% | 501,442 | +41.0% | 0.01% | +25.0% |
| Q4 2021 | $28,835,000 | -18.6% | 355,699 | +16.8% | 0.00% | -20.0% |
| Q3 2021 | $35,431,000 | -44.4% | 304,437 | -20.7% | 0.01% | -37.5% |
| Q2 2021 | $63,684,000 | -26.7% | 384,121 | -38.3% | 0.01% | -38.5% |
| Q1 2021 | $86,850,000 | +22.0% | 622,579 | +51.4% | 0.01% | +18.2% |
| Q4 2020 | $71,186,000 | +39.0% | 411,247 | +11.8% | 0.01% | +10.0% |
| Q3 2020 | $51,222,000 | +7.9% | 367,705 | -7.4% | 0.01% | -9.1% |
| Q2 2020 | $47,463,000 | +122.6% | 397,283 | +86.3% | 0.01% | +83.3% |
| Q1 2020 | $21,322,000 | -19.6% | 213,268 | -5.5% | 0.01% | 0.0% |
| Q4 2019 | $26,530,000 | +58.8% | 225,706 | +16.1% | 0.01% | +50.0% |
| Q3 2019 | $16,707,000 | +66.4% | 194,335 | +25.4% | 0.00% | +33.3% |
| Q2 2019 | $10,043,000 | +2.4% | 154,912 | -1.3% | 0.00% | 0.0% |
| Q1 2019 | $9,811,000 | +69.6% | 156,953 | +5.5% | 0.00% | +50.0% |
| Q4 2018 | $5,786,000 | -56.3% | 148,790 | -35.9% | 0.00% | -33.3% |
| Q3 2018 | $13,235,000 | -38.0% | 232,193 | -13.1% | 0.00% | -50.0% |
| Q2 2018 | $21,334,000 | -9.0% | 267,189 | -1.3% | 0.01% | -14.3% |
| Q1 2018 | $23,452,000 | +22.1% | 270,588 | -2.7% | 0.01% | +40.0% |
| Q4 2017 | $19,204,000 | -10.3% | 278,143 | +18.1% | 0.01% | -16.7% |
| Q3 2017 | $21,403,000 | +20.0% | 235,507 | -1.7% | 0.01% | +20.0% |
| Q2 2017 | $17,837,000 | -67.1% | 239,646 | -58.6% | 0.01% | -37.5% |
| Q1 2017 | $54,254,000 | +18.7% | 579,014 | -7.9% | 0.01% | +14.3% |
| Q4 2016 | $45,694,000 | +77.1% | 628,880 | +154.4% | 0.01% | -22.2% |
| Q3 2016 | $25,805,000 | +193.8% | 247,199 | +107.6% | 0.01% | +200.0% |
| Q2 2016 | $8,784,000 | +100.5% | 119,082 | +52.9% | 0.00% | +50.0% |
| Q1 2016 | $4,382,000 | -14.8% | 77,886 | +2.3% | 0.00% | 0.0% |
| Q4 2015 | $5,141,000 | +12.6% | 76,145 | -22.6% | 0.00% | 0.0% |
| Q3 2015 | $4,566,000 | -36.6% | 98,429 | -26.5% | 0.00% | 0.0% |
| Q2 2015 | $7,201,000 | +141.2% | 133,963 | +115.1% | 0.00% | +100.0% |
| Q1 2015 | $2,985,000 | -19.7% | 62,279 | -35.2% | 0.00% | 0.0% |
| Q4 2014 | $3,717,000 | – | 96,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |